Roslyn Davis

700 total citations
9 papers, 560 citations indexed

About

Roslyn Davis is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Roslyn Davis has authored 9 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Surgery. Recurrent topics in Roslyn Davis's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Biosimilars and Bioanalytical Methods (3 papers) and Influenza Virus Research Studies (2 papers). Roslyn Davis is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Biosimilars and Bioanalytical Methods (3 papers) and Influenza Virus Research Studies (2 papers). Roslyn Davis collaborates with scholars based in Australia, United States and United Kingdom. Roslyn Davis's co-authors include Robert J. Konrad, Jason S. Troutt, William E. Alborn, Guoqing Cao, John C. Cox, Martin J. Pearse, Debbie Drane, Rachael Easton, Samuel D. Wright and Andreas Gille and has published in prestigious journals such as Blood, Journal of Lipid Research and Vaccine.

In The Last Decade

Roslyn Davis

9 papers receiving 551 citations

Peers

Countries citing papers authored by Roslyn Davis

Since Specialization

Citations

This map shows the geographic impact of Roslyn Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roslyn Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roslyn Davis more than expected).

Fields of papers citing papers by Roslyn Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roslyn Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roslyn Davis. The network helps show where Roslyn Davis may publish in the future.

Co-authorship network of co-authors of Roslyn Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Roslyn Davis. A scholar is included among the top collaborators of Roslyn Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roslyn Davis. Roslyn Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	A method for detection of anti-drug antibodies to a biotherapeutic (CSL112) with endogenous counterpart (apolipoprotein A-I) using a novel sample pre-treatment electrochemiluminescence assay 2022 ·Journal of Immunological Methods ·Roslyn Davis, Elena Velkoska, (unknown), (unknown), Andreas Gille, Bronwyn A. Kingwell, Kirstee L. Martin	1
2	Clinical Immunogenicity Risk Assessment Strategy for a Low Risk Monoclonal Antibody 2020 ·The AAPS Journal ·(unknown), Gizette Sperinde, Deborah Finco, Roslyn Davis, Diana Montgomery	5
3	First-in Man, Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients with CD123+ Acute Myeloid Leukemia (AML) in CR at High Risk for Early Relapse 2014 ·Blood ·B. Douglas Smith, Gail J. Roboz, Roland B. Walter, Jessica K. Altman, Anna Ferguson, Tania J. Curcio, (unknown), Linda Garrett, Samantha J. Busfield, Megan Barnden, (unknown), Souravi Ghosh, (unknown), Roslyn Davis, (unknown), (unknown), Mark DeWitte, Debra M. Bensen-Kennedy, Andrew W. Roberts	52
4	A multiple ascending dose study of CSL112, an infused formulation of ApoA‐I 2013 ·The Journal of Clinical Pharmacology ·Rachael Easton, Andreas Gille, Denise D’Andrea, Roslyn Davis, Samuel D. Wright, Charles L. Shear	74
5	A novel method for quantitative measurement of a biomarker in the presence of a therapeutic monoclonal antibody directed against the biomarker 2008 ·Journal of Pharmaceutical and Biomedical Analysis ·Roslyn Davis, Anthony Butterfield, Robert J. Konrad, James S. Bourdage	11
6	A Phase 1 and Correlative Biological Study of CSL360 (anti-CD123 mAb) in AML 2008 ·Blood ·Andrew W. Roberts, Simon He, Kenneth F. Bradstock, Mark Hertzberg, S. T. S. Durrant, David Ritchie, Ian D. Lewis, Paula Marlton, Andrew J. McLachlan, Trina Yeadon, Samantha J. Busfield, Megan Barnden, Roslyn Davis, (unknown), (unknown), Mark Biondo, (unknown), Mark DeWitte, Russell L. Basser	16
7	Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9 2007 ·Journal of Lipid Research ·(unknown), Roslyn Davis, William E. Alborn, Jason S. Troutt, Guoqing Cao, Robert J. Konrad	261
8	Intranasal vaccination with ISCOMATRIX® adjuvanted influenza vaccine 2003 ·Vaccine ·A.R. Coulter, (unknown), Roslyn Davis, Debbie Drane, John C. Cox, David Ryan, Philip Sutton, Steve Rockman, Martin J. Pearse	92
9	Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses 2001 ·Vaccine ·Sigrid Sjölander, Debbie Drane, Roslyn Davis, (unknown), Martin J. Pearse, John C. Cox	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact